Allgemein

The companies agree to a worldwide Human Platelet Lysate (HPL) Patent License and Assignment Agreement regarding Human Platelet Lysate (HPL) cell culture supplements, including redirection of HPL customers from Macopharma to PL BioScience. PL BioScience GmbH, a German life science company specializing in the production and

READ MORE

Becoming human: GMP-compliant supplements for cell therapy We were recently interviewed by European biotech media company Labiotech regarding our thoughts on cell culture reagent challenges, and our line of ELAREM™ Human Platelet Lysate (HPL) for cell therapy. The article features thoughts and quotes from CEO &

READ MORE

A new publication from Kouroupis et al. published in CYTOTHERAPY in July 2020 found out that infrapatellar fat pad (IFP)-mesenchymal stem cells (MSCs) manufactured with human Platelet Lysate (hPL) show enhanced immunomodulatory properties. Findings have potential for a minimally invasive cell therapy for joint disease The authors even

READ MORE
Any questions?
close slider

Any questions?

Please contact us:

support@pl-bioscience.com

+49 (0) 241 95719-100